Company / Depreciation & Amortization
Enovis Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.3B
FY2025
5-year range
$167.9M / $1.3B
FY2021-FY2025
Trend
+44.9%
vs FY2024
Sector context
#9 of 142
Health Care
What the data says
Among 142 Health Care companies, Enovis is in the bottom 6% for depreciation & amortization. Depreciation & Amortization has increased for 3 consecutive years, from $168M in FY2022 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +75.3%. Top quartile in the Health Care sector.
Increased from $187M to $1.3B over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +100.0%
- 5-Year CAGR
- +75.3%
- 10-Year CAGR
- -
Sector benchmark
+286.9% above sector average
Key checks
Key Insights
- Enovis's depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of +75.3%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 44.9% year-over-year.
- Ranks #9 out of 142 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +44.9% |
| FY2024 | $927.8M | +396.2% |
| FY2023 | $187.0M | +11.4% |
| FY2022 | $167.9M | -10.2% |
| FY2021 | $187.0M | +130.3% |
| FY2020 | $81.2M | +11.7% |
| FY2019 | $72.7M | -10.5% |
| FY2018 | $81.2M | -40.7% |
| FY2017 | $137.0M | +6.4% |
| FY2016 | $128.8M | +8.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026